North America Poultry Vaccines Market : Table of Contents

1. Introduction

1.1 Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights

2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research

3.2 Primary Research

3.2.1 Data Triangulation and Validation

4. North America Poultry Vaccines Market Landscape

4.1 Overview

4.3 Ecosystem Analysis

4.3.1 List of Vendors in the Value Chain

5. North America Poultry Vaccines Market – Key Market Dynamics

5.1 Market Drivers

5.2 Market Restraints

5.3 Market Opportunities

5.4 Future Trends

5.5 Impact of Drivers and Restraints

6. North America Poultry Vaccines Market Regional Analysis

6.2 North America Poultry Vaccines Market Revenue 2021-2031 (US$ Million)

6.3 North America Poultry Vaccines Market Forecast Analysis

7. North America Poultry Vaccines Market Analysis – by Type

7.1 Broiler

7.1.1 Overview
7.1.2 Broiler: North America Poultry Vaccines Market – Revenue and Forecast, 2021-2031 (US$ Million)

7.2 Layer

7.2.1 Overview
7.2.2 Layer: North America Poultry Vaccines Market – Revenue and Forecast, 2021-2031 (US$ Million)

8. North America Poultry Vaccines Market Analysis – by Technology

8.1 Live Attenuated Vaccines

8.1.1 Overview
8.1.2 Live Attenuated Vaccines: North America Poultry Vaccines Market – Revenue and Forecast, 2021-2031 (US$ Million)

8.2 Inactivated Vaccines

8.2.1 Overview
8.2.2 Inactivated Vaccines: North America Poultry Vaccines Market – Revenue and Forecast, 2021-2031 (US$ Million)

8.3 Recombinant Vaccines?Dosage Form

8.3.1 Overview
8.3.2 Recombinant Vaccines?Dosage Form : North America Poultry Vaccines Market – Revenue and Forecast, 2021-2031 (US$ Million)

9. North America Poultry Vaccines Market Analysis – by Route Of Administration

9.1 Drinking water

9.1.1 Overview
9.1.2 Drinking water: North America Poultry Vaccines Market – Revenue and Forecast, 2021-2031 (US$ Million)

9.2 Intramuscular

9.2.1 Overview
9.2.2 Intramuscular: North America Poultry Vaccines Market – Revenue and Forecast, 2021-2031 (US$ Million)

9.3 Subcutaneous

9.3.1 Overview
9.3.2 Subcutaneous: North America Poultry Vaccines Market – Revenue and Forecast, 2021-2031 (US$ Million)

10. North America Poultry Vaccines Market – North America Analysis

10.1 Overview

10.2 North America

10.2.1 North America Poultry Vaccines Market Breakdown, by Key Country, 2024 and 2031 (%)
10.2.1.1 North America Poultry Vaccines Market – Revenue and Forecast Analysis – by Country
10.2.1.1 US: North America Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million)

10.2.1.1.1 US: North America Poultry Vaccines Market Breakdown, by Type
10.2.1.1.2 US: North America Poultry Vaccines Market Breakdown, by Technology
10.2.1.1.3 US: North America Poultry Vaccines Market Breakdown, by Route Of Administration

10.2.1.2 Canada: North America Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million)

10.2.1.2.1 Canada: North America Poultry Vaccines Market Breakdown, by Type
10.2.1.2.2 Canada: North America Poultry Vaccines Market Breakdown, by Technology
10.2.1.2.3 Canada: North America Poultry Vaccines Market Breakdown, by Route Of Administration

10.2.1.3 Mexico : North America Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million)

10.2.1.3.1 Mexico : North America Poultry Vaccines Market Breakdown, by Type
10.2.1.3.2 Mexico : North America Poultry Vaccines Market Breakdown, by Technology
10.2.1.3.3 Mexico : North America Poultry Vaccines Market Breakdown, by Route Of Administration

11. Competitive Landscape

11.1 Heat Map Analysis

11.2 Company Positioning and Concentration

12. Industry Landscape

12.1 Overview

12.2 Market Initiative

12.3 Partnerships and Collaborations

12.4 Other Developments

13. Company Profiles

13.1 Boehringer Ingelheim International GmbH.

13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments

13.2 Zoetis Inc.

13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments

13.3 Phibro Animal Health Corp.

13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments

13.4 Dechra Pharmaceuticals PLC.

13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments

13.5 Elanco Animal Health Inc.

13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments

13.6 Merck KGaA.

13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments

13.7 Ceva.

13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments

13.8 Vaccinova AB.

13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments

14. Appendix

14.1 About Business Market Insights

14.2 List of Abbreviations

North America Poultry Vaccines Market